However, some cancer types are characterized by a low expression of CD26, and studies even indicated that induced expression of CD26 in those malignant cells reverted the malignant phenotype and improved control of metastasis, invasion, and proliferation [106,107]. This evidence concerns the gene DPP4 and cancer.